Stop Forum Spam Domain Report for pharmusa.biz

Domain

Details

pharmusa.biz appears in our database 588 times

  • Details

  • Abuse History

  • Whois

Date IP Address Username Email Location Evidence
5-Nov-19 08:23
188.68.3.73
rftpbv
 
unfyqqioy@pharmusa.biz
Czech Republic  
4-Nov-19 04:11
95.85.71.151
mkxupp
 
vruwhppgl@pharmusa.biz
Russian Federation  
4-Nov-19 04:11
95.85.71.151
mkxupp
 
vruwhppgl@pharmusa.biz
Russian Federation  
4-Nov-19 04:11
188.68.0.100
mrqhfh
 
auhxob@pharmusa.biz
United Kingdom  
4-Nov-19 04:11
188.68.0.100
mrqhfh
 
auhxob@pharmusa.biz
United Kingdom  
4-Nov-19 04:11
188.68.0.100
mrqhfh
 
auhxob@pharmusa.biz
United Kingdom  
4-Nov-19 02:32
193.93.195.33
lpmhrt
 
kwpodb@pharmusa.biz
Russian Federation  
3-Nov-19 17:13
95.85.71.209
hfmokx
 
wgabeykgp@pharmusa.biz
Russian Federation  
31-Oct-19 09:44
94.158.22.61
mghwea
 
vvimpukzt@pharmusa.biz
   
31-Oct-19 09:44
94.158.22.61
mghwea
 
vvimpukzt@pharmusa.biz
   
19-Oct-19 21:17
185.101.70.67
etoihj
 
opoiysiyp@pharmusa.biz
United States  
17-Oct-19 10:16
104.156.91.44
lsbnca
 
hztbzoiwl@pharmusa.biz
United States  
17-Oct-19 10:16
104.156.91.44
lsbnca
 
hztbzoiwl@pharmusa.biz
United States  
17-Oct-19 10:16
104.156.91.44
lsbnca
 
hztbzoiwl@pharmusa.biz
United States  
17-Oct-19 10:16
104.156.91.44
lsbnca
 
hztbzoiwl@pharmusa.biz
United States  
14-Oct-19 14:51
85.202.195.105
rhrksd
 
iauxpkazg@pharmusa.biz
   
14-Oct-19 14:51
85.202.195.105
rhrksd
 
iauxpkazg@pharmusa.biz
   
14-Oct-19 14:51
85.202.195.105
rhrksd
 
iauxpkazg@pharmusa.biz
   
14-Oct-19 01:33
5.188.216.142
zbpneh
 
egvescxkw@pharmusa.biz
Netherlands  
14-Oct-19 01:33
5.188.216.142
zbpneh
 
egvescxkw@pharmusa.biz
Netherlands  
14-Oct-19 01:33
5.188.216.142
zbpneh
 
egvescxkw@pharmusa.biz
Netherlands  
13-Oct-19 06:07
188.68.0.148
nmtijr
 
ntlstu@pharmusa.biz
United Kingdom  
13-Oct-19 00:37
95.85.69.133
bvalzw
 
wnsisnoiu@pharmusa.biz
Russian Federation  
12-Oct-19 19:52
46.161.61.200
qgkgcm
 
wbnylocqg@pharmusa.biz
Belgium  
12-Oct-19 19:52
46.161.61.200
qgkgcm
 
wbnylocqg@pharmusa.biz
Belgium  
12-Oct-19 17:30
85.202.194.31
xniuwy
 
qhverbuah@pharmusa.biz
   
12-Oct-19 17:30
85.202.194.31
xniuwy
 
qhverbuah@pharmusa.biz
   
12-Oct-19 16:52
95.85.71.162
bmgvrz
 
czxckotcb@pharmusa.biz
Russian Federation  
12-Oct-19 13:55
95.181.177.24
rftubq
 
pwmsbwuya@pharmusa.biz
Poland Evidence
12-Oct-19 13:51
5.62.159.58
mbyrca
 
ngwawmjkk@pharmusa.biz
Germany  
12-Oct-19 12:05
193.93.195.153
avyjls
 
agflioupp@pharmusa.biz
Russian Federation  
12-Oct-19 10:52
212.115.51.252
efexuc
 
miwimqbfs@pharmusa.biz
   
12-Oct-19 09:25
94.158.22.226
zicemo
 
cpdxljney@pharmusa.biz
   
12-Oct-19 09:05
5.62.159.224
rptnoz
 
bybjlghci@pharmusa.biz
Germany  
12-Oct-19 09:05
5.62.159.224
rptnoz
 
bybjlghci@pharmusa.biz
Germany  
12-Oct-19 09:05
5.62.159.224
rptnoz
 
bybjlghci@pharmusa.biz
Germany  
12-Oct-19 09:05
5.62.159.224
rptnoz
 
bybjlghci@pharmusa.biz
Germany  
12-Oct-19 07:58
2.57.76.99
xzdnyf
 
cchdcligj@pharmusa.biz
   
10-Oct-19 11:40
5.8.47.25
kiagtc
 
jevpfx@pharmusa.biz
Poland  
10-Oct-19 11:40
5.8.47.25
kiagtc
 
jevpfx@pharmusa.biz
Poland  
10-Oct-19 11:40
5.8.47.25
kiagtc
 
jevpfx@pharmusa.biz
Poland  
8-Oct-19 09:48
188.68.3.88
nhfwtb
 
sbmvezshv@pharmusa.biz
Czech Republic  
8-Oct-19 02:02
95.85.68.110
rbuxvh
 
xyvwkdscy@pharmusa.biz
Russian Federation  
7-Oct-19 20:12
193.93.195.238
butrnw
 
nhayglyko@pharmusa.biz
Russian Federation  
7-Oct-19 20:12
193.93.195.238
butrnw
 
nhayglyko@pharmusa.biz
Russian Federation  
7-Oct-19 20:12
193.93.195.238
butrnw
 
nhayglyko@pharmusa.biz
Russian Federation  
7-Oct-19 19:35
212.115.51.20
grgiry
 
lfgublygx@pharmusa.biz
   
7-Oct-19 13:53
194.156.125.182
fairfs
 
gskldixtr@pharmusa.biz
   
7-Oct-19 13:52
37.44.253.89
glzaae
 
vklizgopk@pharmusa.biz
Russian Federation  
7-Oct-19 13:52
37.44.253.89
glzaae
 
vklizgopk@pharmusa.biz
Russian Federation  
7-Oct-19 12:51
5.8.47.20
Dmitriy
 
haxqdguec@pharmusa.biz
Poland  
7-Oct-19 11:53
95.181.177.29
cjxfhu
 
plddximve@pharmusa.biz
Poland  
7-Oct-19 08:14
188.68.3.139
flrtdb
 
ruxuuepgz@pharmusa.biz
Czech Republic  
7-Oct-19 08:08
84.54.58.123
zypzck
 
fuwegbwdv@pharmusa.biz
   
7-Oct-19 08:08
84.54.58.123
zypzck
 
fuwegbwdv@pharmusa.biz
   
7-Oct-19 08:08
84.54.58.123
zypzck
 
fuwegbwdv@pharmusa.biz
   
7-Oct-19 08:05
95.181.218.234
cctzzy
 
pblhvceui@pharmusa.biz
Russian Federation Evidence
6-Oct-19 22:03
46.161.61.64
hlzfdp
 
sjcwncekb@pharmusa.biz
Iceland  
6-Oct-19 21:08
185.233.187.137
rrstde
 
degjlb@pharmusa.biz
   
6-Oct-19 20:33
193.93.195.210
fmcpct
 
czqdjoiuk@pharmusa.biz
Russian Federation  
6-Oct-19 16:03
95.85.71.51
yhezas
 
gcytwnogw@pharmusa.biz
Russian Federation  
6-Oct-19 12:15
94.158.22.123
lbplri
 
shisnyubs@pharmusa.biz
   
6-Oct-19 11:16
94.158.22.139
wtjljg
 
hodyvhybs@pharmusa.biz
   
6-Oct-19 10:55
83.171.252.25
opmfxr
 
blzrzsojw@pharmusa.biz
  Evidence
6-Oct-19 10:08
188.68.3.73
agiglv
 
lyicaiill@pharmusa.biz
Czech Republic  
6-Oct-19 09:03
212.115.51.164
mjujjc
 
gcpdeokkm@pharmusa.biz
   
6-Oct-19 08:01
46.161.60.33
daqgcm
 
gkkcbhpbb@pharmusa.biz
Spain  
6-Oct-19 08:00
91.222.239.87
daqgcm
 
gkkcbhpbb@pharmusa.biz
Russian Federation  
6-Oct-19 08:00
83.171.253.214
daqgcm
 
gkkcbhpbb@pharmusa.biz
   
6-Oct-19 00:22
83.171.252.61
mesqii
 
fvkaefaxn@pharmusa.biz
   
5-Oct-19 20:22
188.68.3.85
lrvrnv
 
zhdpdmuvd@pharmusa.biz
Czech Republic  
5-Oct-19 19:09
194.156.125.56
weyecx
 
mlikaezga@pharmusa.biz
  Evidence
5-Oct-19 18:52
193.93.195.206
gkbwfz
 
keeioc@pharmusa.biz
Russian Federation  
5-Oct-19 17:37
185.89.100.93
ldmrrh
 
meaxkudvd@pharmusa.biz
Germany  
5-Oct-19 15:55
185.89.100.116
augsqb
 
nwmyuqhyx@pharmusa.biz
Germany  
5-Oct-19 15:55
185.89.100.116
augsqb
 
nwmyuqhyx@pharmusa.biz
Germany  
5-Oct-19 15:42
5.62.154.21
qixobp
 
keftzobwv@pharmusa.biz
Latvia  
5-Oct-19 15:40
46.161.60.230
srfjjb
 
zfondtasd@pharmusa.biz
Russian Federation  
5-Oct-19 15:40
46.161.60.230
srfjjb
 
zfondtasd@pharmusa.biz
Russian Federation  
5-Oct-19 15:40
46.161.60.230
srfjjb
 
zfondtasd@pharmusa.biz
Russian Federation  
5-Oct-19 15:39
46.161.60.230
srfjjb
 
zfondtasd@pharmusa.biz
Russian Federation  
5-Oct-19 15:39
83.171.252.216
srfjjb
 
zfondtasd@pharmusa.biz
   
5-Oct-19 13:18
188.68.0.50
tdoxio
 
rhecmw@pharmusa.biz
United Kingdom  
5-Oct-19 07:47
193.93.192.146
tahfme
 
ueobpz@pharmusa.biz
United Kingdom  
5-Oct-19 07:20
212.115.51.163
wprpsu
 
peavkp@pharmusa.biz
   
5-Oct-19 06:10
5.8.47.215
jbjnzq
 
uzqstf@pharmusa.biz
Italy Evidence
5-Oct-19 04:28
85.202.195.153
guzcci
 
bgbtkv@pharmusa.biz
   
5-Oct-19 04:28
188.68.0.165
guzcci
 
bgbtkv@pharmusa.biz
United Kingdom  
5-Oct-19 04:28
194.156.124.213
guzcci
 
bgbtkv@pharmusa.biz
   
5-Oct-19 02:56
2.57.77.15
dpcnst
 
prhlkd@pharmusa.biz
   
5-Oct-19 02:15
94.158.22.221
nmsyqm
 
mrqfrq@pharmusa.biz
   
4-Oct-19 23:53
37.44.253.97
hnxzmb
 
yjmoox@pharmusa.biz
Russian Federation  
4-Oct-19 22:28
5.188.216.22
kxkffc
 
ijfeiz@pharmusa.biz
Netherlands  
4-Oct-19 22:08
185.46.84.167
cictqk
 
snuuuj@pharmusa.biz
Poland Evidence
4-Oct-19 19:55
5.189.207.166
wswsgg
 
jkzleb@pharmusa.biz
Sweden  
4-Oct-19 19:55
5.189.207.166
wswsgg
 
jkzleb@pharmusa.biz
Sweden  
4-Oct-19 19:55
5.189.207.166
wswsgg
 
jkzleb@pharmusa.biz
Sweden  
4-Oct-19 19:55
5.189.207.166
wswsgg
 
jkzleb@pharmusa.biz
Sweden  
4-Oct-19 19:55
95.85.68.204
wswsgg
 
jkzleb@pharmusa.biz
Russian Federation  
4-Oct-19 16:36
85.202.195.65
aerwyh
 
sefmyn@pharmusa.biz
   
21-Sep-19 15:54
95.181.176.151
xruxuv
 
qgzydl@pharmusa.biz
Latvia  
20-Sep-19 13:24
95.85.80.169
dkaevz
 
urwujf@pharmusa.biz
United Kingdom  
20-Sep-19 13:24
95.85.80.169
dkaevz
 
urwujf@pharmusa.biz
United Kingdom  
20-Sep-19 13:24
95.85.80.169
dkaevz
 
urwujf@pharmusa.biz
United Kingdom  
20-Sep-19 13:24
95.85.80.169
dkaevz
 
urwujf@pharmusa.biz
United Kingdom  
20-Sep-19 13:24
95.85.80.169
dkaevz
 
urwujf@pharmusa.biz
United Kingdom  
20-Sep-19 12:17
185.233.187.102
rrfrpq
 
afuplv@pharmusa.biz
   
20-Sep-19 12:17
185.233.187.102
rrfrpq
 
afuplv@pharmusa.biz
   
20-Sep-19 10:08
5.189.205.165
llsesa
 
rpabau@pharmusa.biz
France  
20-Sep-19 10:08
5.189.205.165
llsesa
 
rpabau@pharmusa.biz
France  
19-Sep-19 12:21
85.202.195.100
lljtpn
 
fgbsjx@pharmusa.biz
   
19-Sep-19 12:21
85.202.195.100
lljtpn
 
fgbsjx@pharmusa.biz
   
19-Sep-19 11:59
94.158.22.90
hscrac
 
aejoon@pharmusa.biz
   
18-Sep-19 22:05
2.57.77.117
mrmhxp
 
hixstx@pharmusa.biz
   
18-Sep-19 19:52
95.85.68.156
xshrrm
 
qxfhzw@pharmusa.biz
Russian Federation  
18-Sep-19 19:52
194.156.124.20
xshrrm
 
qxfhzw@pharmusa.biz
   
18-Sep-19 17:13
83.171.252.203
phexdx
 
hvtccd@pharmusa.biz
   
18-Sep-19 12:21
95.85.69.67
tskvmp
 
esnewg@pharmusa.biz
Russian Federation  
18-Sep-19 10:56
212.115.51.76
skufcj
 
becvey@pharmusa.biz
   
18-Sep-19 10:40
95.85.69.60
budmkl
 
rhkbgy@pharmusa.biz
Russian Federation Evidence
18-Sep-19 02:53
95.85.80.89
ralcvd
 
bhelke@pharmusa.biz
United Kingdom  
17-Sep-19 19:55
95.85.69.56
uljdfa
 
oidzib@pharmusa.biz
Russian Federation Evidence
17-Sep-19 18:21
95.85.80.177
nzzxob
 
joysyx@pharmusa.biz
United Kingdom  
17-Sep-19 16:38
37.44.253.42
nfbqzy
 
agvzjs@pharmusa.biz
Russian Federation  
17-Sep-19 16:36
188.68.3.85
rcxgog
 
casjsf@pharmusa.biz
Czech Republic  
17-Sep-19 16:36
188.68.3.85
rcxgog
 
casjsf@pharmusa.biz
Czech Republic  
17-Sep-19 16:36
188.68.3.85
rcxgog
 
casjsf@pharmusa.biz
Czech Republic  
17-Sep-19 16:36
188.68.3.85
rcxgog
 
casjsf@pharmusa.biz
Czech Republic  
17-Sep-19 16:36
188.68.3.85
rcxgog
 
casjsf@pharmusa.biz
Czech Republic  
17-Sep-19 16:01
95.85.68.159
hqmtfx
 
exrmsm@pharmusa.biz
Russian Federation Evidence
17-Sep-19 15:22
5.8.47.250
emoedc
 
limxoc@pharmusa.biz
Italy  
17-Sep-19 15:22
5.8.47.250
emoedc
 
limxoc@pharmusa.biz
Italy  
17-Sep-19 14:54
46.161.61.101
zvsshy
 
wlkcgh@pharmusa.biz
Iceland  
17-Sep-19 14:54
46.161.61.101
zvsshy
 
wlkcgh@pharmusa.biz
Iceland  
17-Sep-19 13:55
91.222.239.125
gerkay
 
qcslis@pharmusa.biz
Russian Federation  
17-Sep-19 13:55
91.222.239.125
gerkay
 
qcslis@pharmusa.biz
Russian Federation  
17-Sep-19 13:55
91.222.239.125
gerkay
 
qcslis@pharmusa.biz
Russian Federation  
17-Sep-19 13:55
91.222.239.125
gerkay
 
qcslis@pharmusa.biz
Russian Federation  
17-Sep-19 13:55
91.222.239.125
gerkay
 
qcslis@pharmusa.biz
Russian Federation  
17-Sep-19 12:39
193.93.192.19
smkppf
 
ehfayq@pharmusa.biz
United Kingdom  
17-Sep-19 12:35
91.222.239.75
lccpmf
 
jeafpo@pharmusa.biz
Russian Federation Evidence
17-Sep-19 12:00
188.68.3.82
nypexh
 
vjeuea@pharmusa.biz
Czech Republic Evidence
17-Sep-19 08:59
5.8.47.64
mtvwzs
 
ygpgqt@pharmusa.biz
Poland  
17-Sep-19 08:59
5.8.47.64
mtvwzs
 
ygpgqt@pharmusa.biz
Poland  
17-Sep-19 08:59
5.8.47.64
mtvwzs
 
ygpgqt@pharmusa.biz
Poland  
17-Sep-19 08:12
95.85.70.157
yhofzz
 
cjpgdv@pharmusa.biz
Russian Federation  
17-Sep-19 03:50
91.222.236.188
fznicl
 
yrfkqc@pharmusa.biz
Russian Federation  
17-Sep-19 03:50
95.85.70.196
fznicl
 
yrfkqc@pharmusa.biz
Russian Federation  
17-Sep-19 03:50
185.46.84.220
dyocow
 
fdawfs@pharmusa.biz
Poland Evidence
16-Sep-19 23:58
46.161.61.165
fcxpoi
 
kqyolk@pharmusa.biz
Belgium  
16-Sep-19 23:58
46.161.61.165
fcxpoi
 
kqyolk@pharmusa.biz
Belgium  
16-Sep-19 23:58
46.161.61.165
fcxpoi
 
kqyolk@pharmusa.biz
Belgium  
16-Sep-19 23:58
46.161.61.165
fcxpoi
 
kqyolk@pharmusa.biz
Belgium  
16-Sep-19 23:58
46.161.61.165
fcxpoi
 
kqyolk@pharmusa.biz
Belgium  
16-Sep-19 22:50
176.119.141.192
guidvn
 
oymmcm@pharmusa.biz
   
16-Sep-19 22:50
5.189.207.248
guidvn
 
oymmcm@pharmusa.biz
Sweden  
16-Sep-19 18:50
91.222.239.77
jihjwh
 
rbryzq@pharmusa.biz
Russian Federation Evidence
16-Sep-19 18:49
95.181.177.108
gymhpq
 
tjhpvt@pharmusa.biz
Poland  
16-Sep-19 18:49
46.161.60.167
jjabvp
 
izrowm@pharmusa.biz
Russian Federation  
16-Sep-19 18:07
5.8.47.232
dfehet
 
zspqag@pharmusa.biz
Italy  
16-Sep-19 17:57
95.85.80.14
okwzpg
 
tgagao@pharmusa.biz
United Kingdom  
16-Sep-19 17:57
193.93.192.91
okwzpg
 
tgagao@pharmusa.biz
United Kingdom  
16-Sep-19 17:52
46.161.61.250
didchk
 
utinos@pharmusa.biz
Belgium  
16-Sep-19 16:25
95.181.176.189
bycdyd
 
xnltrz@pharmusa.biz
Latvia Evidence
16-Sep-19 16:22
95.85.68.253
ulitim
 
ovktti@pharmusa.biz
Russian Federation  
16-Sep-19 16:15
37.44.253.237
nhqstv
 
pcztyj@pharmusa.biz
Russian Federation Evidence
16-Sep-19 16:05
188.68.0.25
mnadmh
 
pmhbsu@pharmusa.biz
United Kingdom Evidence
16-Sep-19 15:45
185.89.100.156
ghwjpl
 
zjemon@pharmusa.biz
European Union Evidence
16-Sep-19 15:20
188.68.0.53
dopwnx
 
yqtqnd@pharmusa.biz
United Kingdom Evidence
16-Sep-19 13:25
84.54.58.76
nfqbjt
 
yurcdi@pharmusa.biz
  Evidence
16-Sep-19 13:24
193.93.192.91
xctmms
 
tihaaq@pharmusa.biz
United Kingdom  
16-Sep-19 13:24
188.68.0.100
xctmms
 
tihaaq@pharmusa.biz
United Kingdom  
16-Sep-19 12:14
95.85.71.69
coppfq
 
ziiozt@pharmusa.biz
Russian Federation  
16-Sep-19 12:14
5.189.206.213
coppfq
 
ziiozt@pharmusa.biz
Finland  
16-Sep-19 09:53
83.171.252.91
ehdans
 
vhrfnc@pharmusa.biz
   
16-Sep-19 09:53
83.171.252.91
ehdans
 
vhrfnc@pharmusa.biz
   
16-Sep-19 08:52
91.222.239.85
ydwedg
 
enloke@pharmusa.biz
Russian Federation  
16-Sep-19 05:10
95.85.68.156
ludywr
 
mdxxru@pharmusa.biz
Russian Federation Evidence
16-Sep-19 04:58
5.189.207.213
dyybxm
 
szjsut@pharmusa.biz
Sweden  
16-Sep-19 04:58
46.161.61.203
dyybxm
 
szjsut@pharmusa.biz
Belgium  
16-Sep-19 04:46
85.202.194.127
wippqa
 
yerqig@pharmusa.biz
   
16-Sep-19 04:46
85.202.194.127
wippqa
 
yerqig@pharmusa.biz
   
16-Sep-19 03:35
5.188.216.90
hxekje
 
vgnubt@pharmusa.biz
Netherlands Evidence
16-Sep-19 03:00
95.85.80.140
fwmozv
 
clbdpr@pharmusa.biz
United Kingdom  
16-Sep-19 02:15
185.46.84.191
myevgg
 
wzyqle@pharmusa.biz
Poland Evidence
16-Sep-19 01:55
83.171.252.83
akueww
 
xhorlb@pharmusa.biz
  Evidence
16-Sep-19 00:35
83.171.253.62
ydpwty
 
syxobi@pharmusa.biz
  Evidence
16-Sep-19 00:21
176.119.141.192
iwojol
 
vtimwn@pharmusa.biz
   
16-Sep-19 00:20
176.119.141.192
iwojol
 
vtimwn@pharmusa.biz
   
16-Sep-19 00:17
176.119.141.192
iwojol
 
vtimwn@pharmusa.biz
   
16-Sep-19 00:16
176.119.141.192
iwojol
 
vtimwn@pharmusa.biz
   
15-Sep-19 23:46
5.189.207.166
vxzwgq
 
yyeonz@pharmusa.biz
Sweden Evidence
15-Sep-19 23:00
95.85.70.241
uduoek
 
bzzvde@pharmusa.biz
Russian Federation  
15-Sep-19 23:00
83.171.252.29
uduoek
 
bzzvde@pharmusa.biz
   
15-Sep-19 22:20
5.188.216.97
bbpbtn
 
mivouu@pharmusa.biz
Netherlands Evidence
15-Sep-19 22:19
212.115.51.111
smgfwi
 
wklwqv@pharmusa.biz
   
15-Sep-19 22:19
5.188.216.234
smgfwi
 
wklwqv@pharmusa.biz
Netherlands  
15-Sep-19 22:06
5.188.216.234
pmuwdy
 
wmgdfs@pharmusa.biz
Netherlands  
15-Sep-19 21:06
185.89.100.79
lkupms
 
jjelpo@pharmusa.biz
Germany  
15-Sep-19 20:43
188.68.3.212
dwreir
 
roeloh@pharmusa.biz
Czech Republic  
15-Sep-19 19:50
95.85.80.22
wdmuph
 
vikerj@pharmusa.biz
United Kingdom Evidence
15-Sep-19 19:26
193.93.192.234
afprrs
 
hymkin@pharmusa.biz
United Kingdom  
15-Sep-19 19:15
94.158.22.122
oobsbh
 
zkaifo@pharmusa.biz
  Evidence
15-Sep-19 18:58
37.44.253.112
hdwfdz
 
oemwjq@pharmusa.biz
Russian Federation  
15-Sep-19 18:40
46.161.61.154
bsbzog
 
iqhvmc@pharmusa.biz
Belgium Evidence
15-Sep-19 18:28
5.8.47.146
uzudiu
 
nwbsnr@pharmusa.biz
Italy  
15-Sep-19 16:33
2.57.77.119
xqdnhr
 
bcdesd@pharmusa.biz
   
15-Sep-19 16:30
185.89.100.88
sfearw
 
ojhccx@pharmusa.biz
Germany Evidence
15-Sep-19 15:38
84.54.58.97
seedoc
 
gjixey@pharmusa.biz
   
15-Sep-19 15:38
84.54.58.97
seedoc
 
gjixey@pharmusa.biz
   
15-Sep-19 15:38
84.54.58.97
seedoc
 
gjixey@pharmusa.biz
   
15-Sep-19 15:38
84.54.58.97
seedoc
 
gjixey@pharmusa.biz
   
15-Sep-19 15:22
95.85.71.111
ozuqem
 
lyyqsx@pharmusa.biz
Russian Federation  
15-Sep-19 14:50
5.62.159.214
ntfvim
 
kkbsdv@pharmusa.biz
Germany  
15-Sep-19 14:50
37.44.253.60
ntfvim
 
kkbsdv@pharmusa.biz
Russian Federation  
15-Sep-19 13:25
193.93.195.235
ailmab
 
oqawxe@pharmusa.biz
Russian Federation Evidence
15-Sep-19 11:27
5.62.154.15
yoymmw
 
fczqyr@pharmusa.biz
Latvia Evidence
15-Sep-19 10:55
94.158.22.95
ybrxfw
 
serayu@pharmusa.biz
   
15-Sep-19 09:07
85.202.195.97
tdenaq
 
tdiupi@pharmusa.biz
   
15-Sep-19 08:21
176.119.141.200
ffmcpo
 
thmamg@pharmusa.biz
   
15-Sep-19 08:18
5.62.159.186
tlwuqd
 
npxrzk@pharmusa.biz
Germany  
15-Sep-19 08:05
95.85.71.33
iamowy
 
awumnh@pharmusa.biz
Russian Federation  
15-Sep-19 08:05
85.202.194.145
iamowy
 
awumnh@pharmusa.biz
   
15-Sep-19 08:00
2.57.76.252
laptpf
 
jnablv@pharmusa.biz
  Evidence
15-Sep-19 07:15
2.57.77.251
xnkosz
 
vydect@pharmusa.biz
  Evidence
15-Sep-19 06:20
95.85.71.151
sdzuog
 
fjyint@pharmusa.biz
Russian Federation  
15-Sep-19 03:56
188.68.0.165
apeubs
 
thuhia@pharmusa.biz
United Kingdom  
15-Sep-19 01:21
84.54.58.222
aecrbj
 
blhrol@pharmusa.biz
   
15-Sep-19 01:21
84.54.58.222
aecrbj
 
blhrol@pharmusa.biz
   
15-Sep-19 01:21
84.54.58.222
aecrbj
 
blhrol@pharmusa.biz
   
15-Sep-19 01:21
84.54.58.222
aecrbj
 
blhrol@pharmusa.biz
   
15-Sep-19 01:14
94.158.22.123
pbxelr
 
rijrth@pharmusa.biz
   
15-Sep-19 01:14
94.158.22.123
pbxelr
 
rijrth@pharmusa.biz
   
14-Sep-19 23:07
95.85.69.25
kvhkfj
 
zlixds@pharmusa.biz
Russian Federation  
14-Sep-19 21:58
176.119.141.211
auozxb
 
ymxnqo@pharmusa.biz
   
14-Sep-19 21:20
95.181.177.41
iimdbz
 
esbwnh@pharmusa.biz
Poland Evidence
14-Sep-19 17:42
83.171.252.61
ryogwl
 
szcsge@pharmusa.biz
   
14-Sep-19 16:43
95.181.218.219
cgpmft
 
rfocbw@pharmusa.biz
Russian Federation  
14-Sep-19 16:43
95.181.218.219
cgpmft
 
rfocbw@pharmusa.biz
Russian Federation  
14-Sep-19 16:43
95.181.218.219
cgpmft
 
rfocbw@pharmusa.biz
Russian Federation  
14-Sep-19 16:36
2.57.76.147
6168
 
nhtutp@pharmusa.biz
   
14-Sep-19 16:00
79.110.28.104
tjtspq
 
mdujki@pharmusa.biz
United Kingdom  
14-Sep-19 16:00
79.110.28.104
tjtspq
 
mdujki@pharmusa.biz
United Kingdom  
14-Sep-19 15:56
185.233.187.18
pjdejw
 
tiphfc@pharmusa.biz
   
14-Sep-19 14:49
185.89.100.42
xzzhjl
 
raqutj@pharmusa.biz
Germany  
14-Sep-19 14:27
185.233.187.128
dpqipw
 
hsslhz@pharmusa.biz
   
14-Sep-19 13:02
193.93.192.226
uthilr
 
qcbtmu@pharmusa.biz
United Kingdom  
14-Sep-19 09:52
5.101.219.216
syxsrl
 
bhtufy@pharmusa.biz
Greece  
14-Sep-19 09:51
5.101.219.216
syxsrl
 
bhtufy@pharmusa.biz
Greece  
14-Sep-19 09:51
5.101.219.216
syxsrl
 
bhtufy@pharmusa.biz
Greece  
14-Sep-19 09:51
5.101.219.216
syxsrl
 
bhtufy@pharmusa.biz
Greece  
14-Sep-19 09:43
95.181.176.174
rcnkpb
 
itsiho@pharmusa.biz
Latvia  
14-Sep-19 09:43
95.181.176.174
rcnkpb
 
itsiho@pharmusa.biz
Latvia  
14-Sep-19 09:22
84.54.58.23
wmelfw
 
fbbxay@pharmusa.biz
  Evidence
14-Sep-19 08:26
79.110.28.19
zhwutk
 
jpkqvr@pharmusa.biz
United Kingdom  
14-Sep-19 08:26
79.110.28.19
zhwutk
 
jpkqvr@pharmusa.biz
United Kingdom  
14-Sep-19 06:09
5.188.216.113
axapzj
 
xbsrfk@pharmusa.biz
Netherlands Evidence
14-Sep-19 06:06
91.222.239.155
qiruip
 
ntsamt@pharmusa.biz
Russian Federation  
14-Sep-19 04:34
95.181.218.163
zrkjfc
 
uuwhvr@pharmusa.biz
Russian Federation Evidence
14-Sep-19 01:33
2.57.77.95
qqvbus
 
thjrur@pharmusa.biz
   
14-Sep-19 01:33
85.202.195.168
qqvbus
 
thjrur@pharmusa.biz
   
13-Sep-19 20:32
5.8.47.19
rmbuyh
 
wfaxgl@pharmusa.biz
Poland  
13-Sep-19 20:31
5.8.47.19
rmbuyh
 
wfaxgl@pharmusa.biz
Poland  
13-Sep-19 20:15
2.57.76.224
uscqkq
 
tzszhr@pharmusa.biz
   
13-Sep-19 19:53
5.189.207.206
zyucxk
 
crhbou@pharmusa.biz
Sweden  
13-Sep-19 19:53
5.189.207.206
zyucxk
 
crhbou@pharmusa.biz
Sweden  
13-Sep-19 19:53
94.158.22.95
zyucxk
 
crhbou@pharmusa.biz
   
13-Sep-19 19:27
188.68.0.53
qivlbd
 
wqllkj@pharmusa.biz
United Kingdom  
13-Sep-19 14:25
95.85.80.242
tnrekk
 
ljcbfb@pharmusa.biz
United Kingdom  
13-Sep-19 14:24
193.93.195.166
yqffuz
 
inshtf@pharmusa.biz
Russian Federation  
13-Sep-19 13:02
5.8.47.64
cngyvz
 
aelary@pharmusa.biz
Poland  
13-Sep-19 12:49
5.8.47.141
penlux
 
szzteu@pharmusa.biz
Italy  
13-Sep-19 11:21
85.202.194.88
bonfhu
 
ialzzx@pharmusa.biz
  Evidence
13-Sep-19 10:10
94.158.22.169
zuoclz
 
zfcywn@pharmusa.biz
   
13-Sep-19 10:08
5.101.219.136
oofotw
 
bpetip@pharmusa.biz
Greece  
13-Sep-19 10:08
5.101.219.136
oofotw
 
bpetip@pharmusa.biz
Greece  
13-Sep-19 10:08
5.101.219.136
oofotw
 
bpetip@pharmusa.biz
Greece  
13-Sep-19 10:08
5.101.219.136
oofotw
 
bpetip@pharmusa.biz
Greece  
13-Sep-19 10:08
5.62.159.214
oofotw
 
bpetip@pharmusa.biz
Germany  
13-Sep-19 06:35
194.156.124.245
zzsaoc
 
ptsdxk@pharmusa.biz
   
31-Aug-19 15:56
95.181.218.133
euehkb
 
xzzrqe@pharmusa.biz
Russian Federation  
31-Aug-19 15:56
95.181.218.133
euehkb
 
xzzrqe@pharmusa.biz
Russian Federation  
29-Aug-19 14:48
212.115.51.141
mcilmb
 
sfmvxm@pharmusa.biz
  Evidence
25-Aug-19 20:20
185.223.161.245
chbytl
 
goqyzj@pharmusa.biz
  Evidence
23-Aug-19 18:04
95.85.70.44
razbxd
 
wkisde@pharmusa.biz
Russian Federation Evidence
16-Aug-19 04:20
93.179.90.17
rvdtea
 
nsrkoc@pharmusa.biz
Czech Republic Evidence
12-Aug-19 17:30
91.222.236.105
gqhgcu
 
oeucuf@pharmusa.biz
Russian Federation Evidence
11-Aug-19 20:15
95.181.177.82
gkvbgn
 
zcioxf@pharmusa.biz
Poland Evidence
10-Aug-19 23:22
79.110.28.50
zpucqr
 
ckuyog@pharmusa.biz
United Kingdom  
10-Aug-19 06:55
188.68.0.20
vpnpgv
 
klhjbs@pharmusa.biz
United Kingdom Evidence
8-Aug-19 00:38
95.85.80.198
qgiqri
 
nirgio@pharmusa.biz
United Kingdom Evidence
7-Aug-19 19:10
188.68.3.75
zkegdy
 
fydyrh@pharmusa.biz
Czech Republic Evidence
6-Aug-19 22:40
95.85.80.220
krwvzb
 
gqxfgu@pharmusa.biz
United Kingdom Evidence
5-Aug-19 23:50
185.251.71.114
ewtspp
 
uiulha@pharmusa.biz
  Evidence
28-Jul-19 16:51
185.251.15.230
xqhdtp
 
diqtyh@pharmusa.biz
   
26-Jul-19 09:50
84.54.58.88
mnsobv
 
pkyoqn@pharmusa.biz
  Evidence
26-Jul-19 09:35
95.181.176.240
duqbkj
 
rdfkyz@pharmusa.biz
Latvia Evidence
26-Jul-19 09:30
46.161.61.194
lnmlyb
 
aurriq@pharmusa.biz
Belgium Evidence
26-Jul-19 09:15
46.161.61.139
dptvls
 
lvtmxa@pharmusa.biz
Belgium Evidence
26-Jul-19 09:00
193.93.195.168
yqavio
 
okyqqq@pharmusa.biz
Russian Federation Evidence
26-Jul-19 08:45
5.101.220.129
qrfvrb
 
bfnibk@pharmusa.biz
Latvia Evidence
26-Jul-19 08:20
95.85.69.174
jcsfgm
 
uxofpg@pharmusa.biz
Russian Federation Evidence
26-Jul-19 08:20
85.202.194.225
wnhbgc
 
inoizi@pharmusa.biz
  Evidence
26-Jul-19 08:00
176.119.141.208
vrvjtd
 
wkaruj@pharmusa.biz
  Evidence
26-Jul-19 07:35
95.181.177.178
zwicwy
 
wkjqbl@pharmusa.biz
Poland Evidence
26-Jul-19 07:30
188.68.0.201
xfrcvx
 
vlvasf@pharmusa.biz
United Kingdom Evidence
26-Jul-19 07:25
95.181.177.249
hxzqxy
 
vcakqz@pharmusa.biz
Poland Evidence
26-Jul-19 07:25
193.32.95.253
ykkobv
 
wekuho@pharmusa.biz
  Evidence
26-Jul-19 07:20
185.251.14.165
ujecwp
 
hawgnm@pharmusa.biz
  Evidence
26-Jul-19 07:10
95.85.71.210
xkevtd
 
xduzuq@pharmusa.biz
Russian Federation Evidence
26-Jul-19 07:05
188.68.0.16
rmvdav
 
aulpjw@pharmusa.biz
United Kingdom Evidence
26-Jul-19 07:05
94.158.22.20
nqueef
 
emaqoe@pharmusa.biz
  Evidence
26-Jul-19 05:45
91.204.14.248
iunshp
 
pblmqg@pharmusa.biz
Germany Evidence
26-Jul-19 05:10
185.251.15.25
wikkvo
 
atzbri@pharmusa.biz
  Evidence
26-Jul-19 01:22
37.44.252.201
akimrn
 
hzpodl@pharmusa.biz
Russian Federation  
26-Jul-19 01:15
185.46.84.189
ddbury
 
lntbzr@pharmusa.biz
Poland Evidence
26-Jul-19 00:35
193.93.192.22
ptimgi
 
pidyiq@pharmusa.biz
United Kingdom Evidence
26-Jul-19 00:10
185.251.14.229
xdeyik
 
kaebod@pharmusa.biz
  Evidence
25-Jul-19 23:15
185.223.161.82
fppfwn
 
fotcan@pharmusa.biz
  Evidence
25-Jul-19 22:45
84.54.58.234
zepiwn
 
yvlosb@pharmusa.biz
  Evidence
25-Jul-19 21:35
194.156.124.123
gbqqml
 
bcxqso@pharmusa.biz
  Evidence
25-Jul-19 21:25
95.181.177.91
mholtp
 
meagvh@pharmusa.biz
Poland Evidence
25-Jul-19 20:34
185.251.71.151
hiooir
 
ncpjgx@pharmusa.biz
   
25-Jul-19 19:25
5.189.205.172
jzzrar
 
gpizgk@pharmusa.biz
France Evidence
25-Jul-19 19:15
83.171.252.29
xwzzhd
 
dhpebz@pharmusa.biz
  Evidence
25-Jul-19 18:25
95.85.70.225
otedyk
 
hnsfae@pharmusa.biz
Russian Federation Evidence
25-Jul-19 16:00
185.251.71.160
pbbbcn
 
mozmbq@pharmusa.biz
  Evidence
25-Jul-19 12:00
95.181.176.208
cnnvxd
 
ndgjyk@pharmusa.biz
Latvia Evidence
25-Jul-19 11:20
91.222.239.14
yhgtnb
 
ljbwcn@pharmusa.biz
Russian Federation Evidence
25-Jul-19 10:35
85.202.194.118
iuykim
 
fqnfrz@pharmusa.biz
  Evidence
25-Jul-19 09:20
85.202.195.206
mfddqi
 
lmexbe@pharmusa.biz
  Evidence
25-Jul-19 09:15
185.251.70.252
eyjcqt
 
tyhnkc@pharmusa.biz
  Evidence
25-Jul-19 09:00
2.57.77.236
txjihz
 
ssczmq@pharmusa.biz
  Evidence
25-Jul-19 08:40
188.68.3.133
cqcnfz
 
cgluik@pharmusa.biz
Czech Republic Evidence
25-Jul-19 08:40
188.68.3.236
xguvhh
 
piswqx@pharmusa.biz
Czech Republic Evidence
25-Jul-19 07:45
185.251.71.128
biijnx
 
uzxgix@pharmusa.biz
  Evidence
25-Jul-19 07:30
91.222.236.199
zfxojz
 
qtidxv@pharmusa.biz
Russian Federation Evidence
25-Jul-19 06:45
185.251.15.140
iwuaan
 
kcrwqo@pharmusa.biz
  Evidence
25-Jul-19 06:20
93.179.90.27
pxeswb
 
kdnfqh@pharmusa.biz
Czech Republic Evidence
25-Jul-19 06:15
185.251.70.203
yfxcmz
 
tjppkp@pharmusa.biz
  Evidence
25-Jul-19 03:15
193.93.192.147
uyosts
 
rpelys@pharmusa.biz
United Kingdom Evidence
25-Jul-19 02:35
94.158.22.165
lunplt
 
svevde@pharmusa.biz
  Evidence
25-Jul-19 00:40
5.101.220.198
expdki
 
dhhogl@pharmusa.biz
Latvia Evidence
24-Jul-19 23:25
91.222.236.103
frknkg
 
jcunbu@pharmusa.biz
Russian Federation Evidence
24-Jul-19 22:35
212.115.51.24
meadsg
 
vtfwqj@pharmusa.biz
  Evidence
24-Jul-19 22:35
95.85.70.241
ovinni
 
wbesbe@pharmusa.biz
Russian Federation Evidence
24-Jul-19 22:30
185.14.194.68
kupsvi
 
tclfsq@pharmusa.biz
United Kingdom  
24-Jul-19 20:15
95.85.80.167
grfsxt
 
kkgubb@pharmusa.biz
United Kingdom Evidence
24-Jul-19 13:35
95.85.70.225
sgdncw
 
pxfvtf@pharmusa.biz
Russian Federation Evidence
24-Jul-19 12:30
91.222.236.75
cigqxq
 
pkvtfb@pharmusa.biz
Russian Federation Evidence
24-Jul-19 12:02
91.204.14.229
nijavo
 
lzglas@pharmusa.biz
Germany Evidence
24-Jul-19 11:30
5.189.206.223
cnkgmm
 
crftzg@pharmusa.biz
Finland Evidence
24-Jul-19 10:40
91.222.236.102
qazjco
 
iphoen@pharmusa.biz
Russian Federation Evidence
24-Jul-19 10:05
188.68.0.136
zdghqb
 
daesrc@pharmusa.biz
United Kingdom Evidence
24-Jul-19 08:45
95.85.80.208
rqokzc
 
nmmnlq@pharmusa.biz
United Kingdom Evidence
24-Jul-19 06:25
91.222.239.22
emopys
 
fesokb@pharmusa.biz
Russian Federation Evidence
24-Jul-19 05:35
93.179.90.112
fxxzct
 
dkacfc@pharmusa.biz
Czech Republic Evidence
24-Jul-19 04:35
185.251.15.174
duxazq
 
vuwfpg@pharmusa.biz
  Evidence
24-Jul-19 04:15
193.93.195.205
iunwjz
 
gyxror@pharmusa.biz
Russian Federation Evidence
23-Jul-19 20:45
95.85.68.50
dqfgvv
 
ukomoq@pharmusa.biz
Russian Federation Evidence
23-Jul-19 18:30
95.181.176.33
lngiey
 
axdifg@pharmusa.biz
Latvia Evidence
23-Jul-19 17:00
193.32.95.25
rirwbf
 
wifsof@pharmusa.biz
  Evidence
23-Jul-19 10:00
85.202.194.225
agstfx
 
rvfgiq@pharmusa.biz
  Evidence
23-Jul-19 06:55
94.158.22.223
ddweob
 
vrpcip@pharmusa.biz
  Evidence
12-Jul-19 10:00
95.85.69.200
cgcglw
 
yagerh@pharmusa.biz
Russian Federation  
12-Jul-19 10:00
188.68.0.87
cgcglw
 
yagerh@pharmusa.biz
United Kingdom  
12-Jul-19 07:20
91.204.14.204
rpiznm
 
vpncag@pharmusa.biz
Germany Evidence
12-Jul-19 06:44
193.93.192.174
eufcin
 
rsbgsw@pharmusa.biz
United Kingdom  
12-Jul-19 06:44
95.181.176.110
eufcin
 
rsbgsw@pharmusa.biz
Latvia  
12-Jul-19 04:43
5.188.216.198
rqukmh
 
jsiiye@pharmusa.biz
Netherlands Evidence
12-Jul-19 01:56
95.85.80.26
rqfkgo
 
dknmzf@pharmusa.biz
United Kingdom Evidence
12-Jul-19 01:00
83.171.253.52
dexoyf
 
pzvytd@pharmusa.biz
  Evidence
12-Jul-19 00:45
95.85.68.199
ayglhg
 
ghhhzn@pharmusa.biz
Russian Federation Evidence
11-Jul-19 21:58
85.202.194.225
cuwdcj
 
netfrt@pharmusa.biz
   
11-Jul-19 21:58
5.101.220.198
cuwdcj
 
netfrt@pharmusa.biz
Latvia  
11-Jul-19 21:22
5.189.206.174
ubgwqj
 
nawprm@pharmusa.biz
Finland  
11-Jul-19 21:22
185.251.14.30
ubgwqj
 
nawprm@pharmusa.biz
   
11-Jul-19 19:23
2.57.76.248
zjrxvf
 
hakpxa@pharmusa.biz
   
11-Jul-19 19:23
85.202.194.111
zjrxvf
 
hakpxa@pharmusa.biz
   
11-Jul-19 18:50
185.251.14.195
yccrum
 
fxjxlj@pharmusa.biz
   
11-Jul-19 16:05
5.101.220.191
cxhtwh
 
fddtms@pharmusa.biz
Latvia  
11-Jul-19 13:45
91.222.236.117
zjooph
 
bwyato@pharmusa.biz
Russian Federation Evidence
11-Jul-19 12:18
95.181.177.79
ygjfhs
 
vccpuh@pharmusa.biz
Poland  
11-Jul-19 07:55
185.251.70.142
juvfvc
 
fvhpxb@pharmusa.biz
  Evidence
11-Jul-19 00:15
95.181.177.249
xtjajw
 
enmygc@pharmusa.biz
Poland  
11-Jul-19 00:15
95.85.80.141
xtjajw
 
enmygc@pharmusa.biz
United Kingdom  
10-Jul-19 21:20
185.251.15.75
qxyoih
 
qcyfex@pharmusa.biz
  Evidence
10-Jul-19 17:35
46.161.61.138
bxjsat
 
hwygou@pharmusa.biz
Belgium  
10-Jul-19 17:35
95.181.177.105
bxjsat
 
hwygou@pharmusa.biz
Poland  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:22
95.85.80.158
nygkjq
 
alqmkm@pharmusa.biz
United Kingdom  
10-Jul-19 16:21
95.181.218.188
qhjhcc
 
seokmc@pharmusa.biz
Russian Federation  
10-Jul-19 16:21
5.62.154.125
qhjhcc
 
seokmc@pharmusa.biz
Latvia  
10-Jul-19 15:11
185.223.161.29
yppkbk
 
hlbnlr@pharmusa.biz
   
10-Jul-19 10:33
95.85.80.236
envvlk
 
sqqpew@pharmusa.biz
United Kingdom Evidence
10-Jul-19 01:50
95.181.218.196
ppjhfj
 
vaxlex@pharmusa.biz
Russian Federation Evidence
9-Jul-19 23:16
5.101.219.227
enlrdn
 
mkpxqd@pharmusa.biz
Greece  
9-Jul-19 16:44
95.85.69.74
ikoxkd
 
aqwupy@pharmusa.biz
Russian Federation  
9-Jul-19 16:33
95.85.71.70
jkkizs
 
rmljca@pharmusa.biz
Russian Federation  
9-Jul-19 16:28
95.85.80.163
bdlpwa
 
kuldbw@pharmusa.biz
United Kingdom  
9-Jul-19 16:28
5.101.220.183
bdlpwa
 
kuldbw@pharmusa.biz
Latvia  
9-Jul-19 10:30
95.85.80.163
zdjmag
 
xqysig@pharmusa.biz
United Kingdom Evidence
9-Jul-19 06:32
95.181.176.77
ysaedh
 
vtndsf@pharmusa.biz
Latvia  
9-Jul-19 00:35
95.181.218.158
sjugua
 
redqva@pharmusa.biz
Russian Federation Evidence
8-Jul-19 22:18
5.101.219.160
cshykc
 
frdwki@pharmusa.biz
Greece  
8-Jul-19 20:50
2.57.76.159
ucgndv
 
jiweps@pharmusa.biz
  Evidence
8-Jul-19 19:51
5.188.216.201
xbkijr
 
ydspqw@pharmusa.biz
Netherlands  
8-Jul-19 18:25
95.85.80.220
mfhlro
 
vxdiif@pharmusa.biz
United Kingdom Evidence
8-Jul-19 16:15
194.156.125.25
wvvngb
 
yciqpl@pharmusa.biz
   
8-Jul-19 12:58
83.171.252.33
twqabk
 
dyngzo@pharmusa.biz
   
8-Jul-19 11:19
83.171.252.74
xhjths
 
tfmibc@pharmusa.biz
   
8-Jul-19 11:08
95.85.80.198
qcosba
 
gccgkx@pharmusa.biz
United Kingdom  
8-Jul-19 07:51
188.68.0.216
zdrnjd
 
vqwtjg@pharmusa.biz
United Kingdom  
7-Jul-19 22:57
5.188.216.198
cxoagu
 
diyedw@pharmusa.biz
Netherlands  
7-Jul-19 21:32
185.251.15.174
nolhza
 
uyfgtv@pharmusa.biz
   
7-Jul-19 21:32
46.161.60.237
nolhza
 
uyfgtv@pharmusa.biz
Russian Federation  
7-Jul-19 20:29
91.222.239.206
rtldvc
 
vzgfmy@pharmusa.biz
Russian Federation  
7-Jul-19 14:10
185.251.70.247
ckbsjq
 
jojbop@pharmusa.biz
   
7-Jul-19 13:54
5.101.219.136
rmtuhv
 
sqbrlu@pharmusa.biz
Greece  
7-Jul-19 13:53
95.85.68.234
rmtuhv
 
sqbrlu@pharmusa.biz
Russian Federation  
7-Jul-19 13:53
5.189.206.185
rmtuhv
 
sqbrlu@pharmusa.biz
Finland  
7-Jul-19 11:03
193.93.192.170
luvhii
 
zgxvam@pharmusa.biz
United Kingdom  
7-Jul-19 08:06
95.181.218.178
qvymqu
 
bqhnzg@pharmusa.biz
Russian Federation  
7-Jul-19 08:06
93.179.90.58
qvymqu
 
bqhnzg@pharmusa.biz
Czech Republic  
7-Jul-19 06:29
95.85.71.180
iopveb
 
slbpuy@pharmusa.biz
Russian Federation  
4-Jul-19 14:24
188.68.3.218
eyjkbj
 
jzidpd@pharmusa.biz
Czech Republic  
2-Jul-19 21:46
37.9.44.219
ffomsk
 
ndcxivawo@pharmusa.biz
United States  
1-Jul-19 23:40
188.68.3.218
eyjkbj
 
jzidpd@pharmusa.biz
Czech Republic  
1-Jul-19 10:48
194.156.124.216
bbtpde
 
etrrji@pharmusa.biz
   
30-Jun-19 22:42
95.85.69.211
rfamzg
 
gvqhto@pharmusa.biz
Russian Federation  
30-Jun-19 22:05
95.181.218.240
fcuutv
 
vamkdd@pharmusa.biz
Russian Federation Evidence
30-Jun-19 20:25
95.181.176.21
zanpjq
 
bjadpx@pharmusa.biz
Latvia Evidence
30-Jun-19 19:46
176.119.141.137
ontphz
 
mytias@pharmusa.biz
   
30-Jun-19 17:35
5.101.220.165
jbpklm
 
bvlogd@pharmusa.biz
Latvia Evidence
30-Jun-19 15:10
95.85.68.180
sjvxey
 
nxgoel@pharmusa.biz
Russian Federation Evidence
30-Jun-19 15:09
91.222.236.153
noivvf
 
tsqtdl@pharmusa.biz
Russian Federation  
30-Jun-19 12:00
193.93.192.106
mgbiyw
 
ibazqm@pharmusa.biz
United Kingdom Evidence
30-Jun-19 08:37
185.251.70.247
aqchwm
 
dumcyl@pharmusa.biz
   
30-Jun-19 08:09
91.222.239.119
yjoujp
 
cnypmc@pharmusa.biz
Russian Federation  
29-Jun-19 17:20
188.68.3.236
qsuhvs
 
ylebfg@pharmusa.biz
Czech Republic Evidence
29-Jun-19 14:57
95.85.70.225
ebxini
 
awayqt@pharmusa.biz
Russian Federation Evidence
29-Jun-19 11:43
193.93.192.231
ctxkug
 
udsnbi@pharmusa.biz
United Kingdom  
29-Jun-19 09:52
91.222.239.22
szbesw
 
eltoik@pharmusa.biz
Russian Federation  
29-Jun-19 05:55
5.189.206.223
gcnylw
 
igwbbr@pharmusa.biz
Finland Evidence
29-Jun-19 01:55
188.68.3.133
wkugsu
 
kzikos@pharmusa.biz
Czech Republic Evidence
28-Jun-19 22:27
185.223.161.74
zzqqvt
 
tykukm@pharmusa.biz
   
28-Jun-19 14:07
185.223.161.122
zxxdil
 
jtvkop@pharmusa.biz
   
28-Jun-19 13:22
95.181.176.107
acnbsm
 
mcndyc@pharmusa.biz
Latvia  
28-Jun-19 13:22
83.171.252.168
acnbsm
 
mcndyc@pharmusa.biz
   
28-Jun-19 11:05
95.85.69.241
venwds
 
nkwzmw@pharmusa.biz
Russian Federation  
28-Jun-19 10:25
95.85.69.162
yrxwjp
 
okcilx@pharmusa.biz
Russian Federation  
28-Jun-19 10:25
2.57.76.217
yrxwjp
 
okcilx@pharmusa.biz
   
28-Jun-19 09:27
193.32.95.51
ukarxy
 
grnxau@pharmusa.biz
  Evidence
28-Jun-19 08:45
94.158.22.42
opticp
 
tgapgh@pharmusa.biz
  Evidence
28-Jun-19 06:33
185.223.161.212
uhuxjw
 
xbxuva@pharmusa.biz
   
28-Jun-19 05:50
95.85.69.28
kvcsgr
 
jwdtqu@pharmusa.biz
Russian Federation Evidence
28-Jun-19 05:49
185.89.100.137
xhbqbk
 
xqtooz@pharmusa.biz
European Union  
28-Jun-19 04:44
79.110.28.21
Steve Fox
 
puhdjv@pharmusa.biz
United Kingdom  
28-Jun-19 03:17
95.181.176.21
dabkxe
 
nfnkim@pharmusa.biz
Latvia  
28-Jun-19 03:17
37.44.253.57
dabkxe
 
nfnkim@pharmusa.biz
Russian Federation  
28-Jun-19 01:55
95.85.80.141
gboypa
 
ijphcs@pharmusa.biz
United Kingdom Evidence
27-Jun-19 22:53
188.68.3.169
qxttjg
 
ixpahv@pharmusa.biz
Czech Republic  
27-Jun-19 19:36
46.161.60.27
msdpuc
 
ajtbqt@pharmusa.biz
Spain  
27-Jun-19 15:14
188.68.3.236
qqxtri
 
eegodi@pharmusa.biz
Czech Republic  
27-Jun-19 15:11
194.156.125.160
gafdbt
 
axhepe@pharmusa.biz
   
27-Jun-19 14:40
94.158.22.25
qcqdov
 
fqvdat@pharmusa.biz
  Evidence
27-Jun-19 13:13
193.93.192.145
clyfsl
 
qwknrv@pharmusa.biz
United Kingdom  
27-Jun-19 13:06
84.54.58.101
wysjig
 
hunery@pharmusa.biz
   
27-Jun-19 12:43
212.115.51.179
uemqqn
 
soenrs@pharmusa.biz
   
27-Jun-19 12:43
185.251.14.108
uemqqn
 
soenrs@pharmusa.biz
   
27-Jun-19 08:24
188.68.3.68
ofzfvp
 
yrbwwx@pharmusa.biz
Czech Republic  
27-Jun-19 08:24
95.85.71.165
ofzfvp
 
yrbwwx@pharmusa.biz
Russian Federation  
27-Jun-19 07:43
188.68.3.244
vciatp
 
xjfwhi@pharmusa.biz
Czech Republic  
27-Jun-19 06:28
46.161.60.204
snkndr
 
ubmgrm@pharmusa.biz
Russian Federation  
27-Jun-19 06:28
84.54.58.239
snkndr
 
ubmgrm@pharmusa.biz
   
27-Jun-19 04:08
185.251.71.52
nqqaqd
 
elswub@pharmusa.biz
   
27-Jun-19 04:07
185.251.71.52
nqqaqd
 
elswub@pharmusa.biz
   
27-Jun-19 04:07
95.85.70.254
nqqaqd
 
elswub@pharmusa.biz
Russian Federation  
27-Jun-19 02:40
185.251.70.115
lwntxo
 
qurjcd@pharmusa.biz
  Evidence
27-Jun-19 02:38
193.32.95.129
goewkg
 
bvsflc@pharmusa.biz
   
27-Jun-19 02:38
193.32.95.129
goewkg
 
bvsflc@pharmusa.biz
   
27-Jun-19 02:20
185.46.84.130
mhvitk
 
jvbhxm@pharmusa.biz
Poland Evidence
26-Jun-19 21:40
46.161.61.55
owxdfz
 
lbaltv@pharmusa.biz
Iceland  
26-Jun-19 21:37
176.119.141.27
iidmwl
 
hmmxnh@pharmusa.biz
   
26-Jun-19 20:06
194.156.125.154
jfzyok
 
fvkaxu@pharmusa.biz
   
26-Jun-19 16:00
84.54.58.88
ucvpeo
 
rdrsmi@pharmusa.biz
   
22-Jun-19 04:50
95.181.218.15
vqfsmp
 
wtunrnhuc@pharmusa.biz
United States Evidence
22-Jun-19 03:44
5.62.153.79
uoyeib
 
fkzbpftpd@pharmusa.biz
United States  
22-Jun-19 00:39
5.62.156.15
hjfsbg
 
okcylqxtf@pharmusa.biz
United States  
21-Jun-19 23:15
185.46.85.213
crfwms
 
rgssqmzrp@pharmusa.biz
United States Evidence
21-Jun-19 20:03
5.62.153.93
sqkuyz
 
acqzhqarv@pharmusa.biz
United States  
21-Jun-19 18:49
185.14.193.234
bnhalp
 
dstbailbj@pharmusa.biz
Canada  
21-Jun-19 18:49
185.14.193.15
bnhalp
 
dstbailbj@pharmusa.biz
Canada  
21-Jun-19 16:30
95.85.81.153
ibpyqb
 
tnhfmuywi@pharmusa.biz
United States Evidence
21-Jun-19 11:45
185.71.1.179
tkpydt
 
vlwurpwzz@pharmusa.biz
United States  
21-Jun-19 05:48
185.71.2.80
tkmswq
 
hbsuasbyg@pharmusa.biz
United States  
21-Jun-19 02:45
79.110.28.195
cbrgrj
 
mjgbxcryz@pharmusa.biz
United States Evidence
20-Jun-19 22:41
91.204.14.52
ldequk
 
qldkldxyu@pharmusa.biz
United States  
20-Jun-19 22:32
5.62.153.161
xlpofk
 
sweonwyhv@pharmusa.biz
United States  
20-Jun-19 21:20
95.181.218.11
ywpanr
 
sdvvxupng@pharmusa.biz
United States Evidence
20-Jun-19 17:47
95.85.81.108
qlasnf
 
lgirgmhgt@pharmusa.biz
United States  
20-Jun-19 17:01
95.85.81.156
mbcavt
 
scjtgmuhz@pharmusa.biz
United States  
20-Jun-19 17:01
185.71.2.47
mbcavt
 
scjtgmuhz@pharmusa.biz
United States  
20-Jun-19 12:03
5.62.156.114
cggfxk
 
qgqonbocg@pharmusa.biz
United States  
20-Jun-19 06:56
5.189.205.38
msfult
 
mhhadqscq@pharmusa.biz
Canada  
20-Jun-19 06:56
5.62.153.16
msfult
 
mhhadqscq@pharmusa.biz
United States  
18-Jun-19 15:12
185.101.70.201
hcfhyi
 
sfnqmtmoe@pharmusa.biz
United States  
17-Jun-19 06:41
91.200.83.42
zwnxmw
 
phkmvoehu@pharmusa.biz
United States  
12-Jun-19 20:49
5.62.156.201
zysykx
 
gdxooizfi@pharmusa.biz
United States  
12-Jun-19 20:25
5.189.205.31
wvhdkj
 
dditraugb@pharmusa.biz
Canada  
12-Jun-19 20:08
185.71.2.155
gzhnjx
 
sadufrtyz@pharmusa.biz
United States  
12-Jun-19 15:13
5.62.156.233
uwqghd
 
ffmtpgoph@pharmusa.biz
United States  
12-Jun-19 14:27
5.62.153.125
sssapz
 
pajlqgoms@pharmusa.biz
United States  
12-Jun-19 14:24
5.8.44.56
nmsixg
 
xpimysvum@pharmusa.biz
Mexico  
12-Jun-19 13:30
185.71.2.124
mijtkw
 
ajexrvriz@pharmusa.biz
United States Evidence
12-Jun-19 12:57
185.46.85.154
xeatlf
 
kgnnwyxtf@pharmusa.biz
United States  
12-Jun-19 12:42
79.110.31.198
qfffqx
 
uuovdqrmu@pharmusa.biz
Canada  
12-Jun-19 09:28
93.179.89.172
gxccpj
 
nvtabzada@pharmusa.biz
United States  
12-Jun-19 08:48
5.62.156.201
dxrnwq
 
atptsuokt@pharmusa.biz
United States  
12-Jun-19 06:38
185.14.193.103
asybus
 
juokoqgmd@pharmusa.biz
Canada  
12-Jun-19 03:37
185.71.3.110
ynyeab
 
xanxqbmni@pharmusa.biz
United States  
12-Jun-19 00:18
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 23:57
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 22:03
5.8.44.127
qtvmfn
 
inzchhzjg@pharmusa.biz
Mexico  
11-Jun-19 21:58
37.9.45.38
bukigt
 
shtygbtnn@pharmusa.biz
United States  
11-Jun-19 21:54
5.189.205.34
kkonbf
 
qbcyynvrw@pharmusa.biz
Canada  
11-Jun-19 20:04
93.179.91.62
ncsawi
 
fzhheucfd@pharmusa.biz
United States  
11-Jun-19 17:44
5.62.153.33
reolhk
 
gsnzjcadv@pharmusa.biz
United States  
11-Jun-19 16:28
37.9.44.17
wtpbnl
 
wwyywdyyi@pharmusa.biz
United States  
11-Jun-19 16:14
5.8.45.54
ddvpet
 
ljolwcmiz@pharmusa.biz
Brazil  
11-Jun-19 14:57
95.85.81.118
nedzyc
 
bggmzzbvf@pharmusa.biz
United States  
11-Jun-19 14:36
79.110.28.207
fhutam
 
quyawjxzx@pharmusa.biz
United States  
11-Jun-19 14:16
5.8.45.234
xdfkiv
 
nmulcvgex@pharmusa.biz
Chile  
11-Jun-19 14:16
95.85.81.146
xdfkiv
 
nmulcvgex@pharmusa.biz
United States  
11-Jun-19 12:54
5.189.207.31
ptzzoj
 
kzustwwjv@pharmusa.biz
United States  
11-Jun-19 12:50
95.85.81.175
hvpoqw
 
jmmdxvliv@pharmusa.biz
United States Evidence
11-Jun-19 11:46
37.9.45.105
goolto
 
zrqavujky@pharmusa.biz
United States  
11-Jun-19 10:41
95.181.218.39
wrbolj
 
iiuuslhod@pharmusa.biz
United States  
11-Jun-19 10:37
5.62.158.86
dmwkah
 
cgorygemh@pharmusa.biz
United States  
11-Jun-19 09:36
91.204.14.57
kolmud
 
merxxzmde@pharmusa.biz
United States  
11-Jun-19 09:00
5.62.158.124
rnerqc
 
eejyryffy@pharmusa.biz
United States  
11-Jun-19 06:53
5.62.156.210
jgaxku
 
hmfpoicdi@pharmusa.biz
United States  
11-Jun-19 06:52
185.71.2.162
jgaxku
 
hmfpoicdi@pharmusa.biz
United States  
11-Jun-19 06:50
37.9.45.34
xknknd
 
kypfmhzfi@pharmusa.biz
United States Evidence
11-Jun-19 06:24
95.85.81.176
hvdrvt
 
xklfbfnae@pharmusa.biz
United States Evidence
11-Jun-19 05:53
5.8.44.115
yuzaro
 
hmcuxloag@pharmusa.biz
Mexico  
11-Jun-19 03:13
185.71.2.65
vzoljb
 
ckwqvlckj@pharmusa.biz
United States Evidence
11-Jun-19 02:02
5.189.206.34
emhtdz
 
bnyrxesrs@pharmusa.biz
United States Evidence
11-Jun-19 02:02
5.189.205.78
xoirds
 
locjljwms@pharmusa.biz
Canada Evidence
11-Jun-19 00:48
95.85.81.37
sicglq
 
vpocrsyis@pharmusa.biz
United States  
11-Jun-19 00:00
5.62.153.84
jzdiwt
 
sntftnsfk@pharmusa.biz
United States  
10-Jun-19 23:46
185.71.2.36
lsjbku
 
ftfiaazwz@pharmusa.biz
United States  
10-Jun-19 23:46
185.71.2.36
lsjbku
 
ftfiaazwz@pharmusa.biz
United States  
10-Jun-19 22:20
93.179.89.181
eeguei
 
sxllkrqtr@pharmusa.biz
United States  
10-Jun-19 19:43
5.8.45.235
yivtgs
 
ezfdxgrfs@pharmusa.biz
Chile  
10-Jun-19 16:54
5.8.44.245
owilgc
 
otjltbhbo@pharmusa.biz
Panama  
10-Jun-19 11:34
5.62.156.84
smxcey
 
iobacywcv@pharmusa.biz
United States  
10-Jun-19 10:28
5.62.156.144
szbyxd
 
vmlyqrblr@pharmusa.biz
United States  
10-Jun-19 09:28
185.101.70.36
iiguja
 
aombchfdm@pharmusa.biz
United States  
9-Jun-19 22:39
5.62.156.234
dvfyif
 
rbagdulvb@pharmusa.biz
United States  
9-Jun-19 21:27
5.8.44.60
ejnsbu
 
ynpsstldz@pharmusa.biz
Mexico  
9-Jun-19 15:35
5.62.153.110
thruto
 
ynxbigomo@pharmusa.biz
United States  
9-Jun-19 15:19
5.62.156.128
ghmvfe
 
joaaeijxk@pharmusa.biz
United States Evidence
9-Jun-19 14:52
5.8.44.188
gqajgr
 
tgytppybl@pharmusa.biz
Panama  
9-Jun-19 14:04
5.62.153.177
klwsrb
 
zoldogjdn@pharmusa.biz
United States  
9-Jun-19 12:18
178.57.66.201
eixtmi
 
mgqtiotxn@pharmusa.biz
United States  
9-Jun-19 11:58
185.101.70.87
tgcgau
 
luifvadut@pharmusa.biz
United States  
9-Jun-19 11:19
185.71.0.219
qqfczy
 
uimuwqmxw@pharmusa.biz
United States  
9-Jun-19 10:22
5.62.158.69
bmecmh
 
czjyopdus@pharmusa.biz
United States  
9-Jun-19 10:17
185.71.2.28
abrvmo
 
owrulpzur@pharmusa.biz
United States  
9-Jun-19 09:46
185.46.85.223
sfxpot
 
hyaubatqy@pharmusa.biz
United States  
9-Jun-19 08:04
185.46.85.173
pkmegr
 
moonxcuuf@pharmusa.biz
United States  
9-Jun-19 07:32
95.85.81.20
gvkrhs
 
zbdfwzhpq@pharmusa.biz
United States  
9-Jun-19 07:09
5.62.156.111
dfigfh
 
ylckblasd@pharmusa.biz
United States Evidence
9-Jun-19 06:15
185.71.2.68
yubzet
 
vowgbvotl@pharmusa.biz
United States  
9-Jun-19 05:34
5.8.45.39
ztnkav
 
gknfirxrf@pharmusa.biz
Brazil  
9-Jun-19 05:34
5.62.156.48
ztnkav
 
gknfirxrf@pharmusa.biz
United States  
9-Jun-19 05:30
5.8.45.39
ckjway
 
thxjhqbqz@pharmusa.biz
Brazil Evidence
9-Jun-19 05:01
91.200.83.88
hsfjya
 
wfiaekpcz@pharmusa.biz
United States Evidence
8-Jun-19 21:11
5.189.205.120
shopax
 
pcfqlujjt@pharmusa.biz
Canada  
8-Jun-19 19:51
79.110.31.195
oxtkqq
 
mhrumuipt@pharmusa.biz
Canada  
8-Jun-19 19:40
185.71.1.227
pbspxk
 
rwzmgflzc@pharmusa.biz
United States  
8-Jun-19 17:49
5.8.45.67
zuxthu
 
jjitdwjwf@pharmusa.biz
Brazil  
8-Jun-19 16:35
5.62.156.144
acwtpn
 
opvnuemiq@pharmusa.biz
United States  
8-Jun-19 12:13
5.8.45.83
ckzqwo
 
otlglypub@pharmusa.biz
Brazil  
8-Jun-19 10:58
95.85.81.176
zhiwzn
 
iycrciedz@pharmusa.biz
United States  
Legend
toxic Toxic IP address or "bad" email domain
tor TOR exit node
Highlighted Hot IP or disposable email address

Abuse History for domain pharmusa.biz

Close
Close